102.095 articles found

Digital mobility assessment using wearable devices in people with Parkinson's disease: a feasibility and implementation study in Ghana (TraPCAf) compared with a UK cohort.

Bicer M, Kirk C, Agoriwo M, Cham M, Akpalu A, Okubadejo N, Sarvestan J, Lumsdon J, Okkaoglu Y, Brittain K, McArdle R, Alcock L, Yarnall AJ, Fothergill-Misbah N, Walker R, Rochester L, Del Din S, TraPCAf.

Front Aging Neurosci · 2026-10-02

DOI: 10.3389/fnagi.2026.1899045PMID: 42890933

Identification of a shared blood-brain transcriptomic signature in Parkinson's disease using bioinformatic and network pharmacology approaches.

Mohammad H, Singh A, Bansal D.

Neuroscience · 2026-10-02

DOI: 10.1016/j.neuroscience.2026.09.044PMID: 42826760

Estradiol attenuates cardiac apoptosis and modulates cardiovascular remodeling in ovariectomized female rats with 6-hydroxydopamine-induced parkinsonism.

de Campos BH, Borges FH, Ariza D, de Jager L, Reginato GS, Gonçalves AB, Martins Novais Padrão AI, Fonseca H, Pinge-Filho P, Crestani CC, Martins-Pinge MC.

Physiol Behav · 2026-10-02

DOI: 10.1016/j.physbeh.2026.115520PMID: 42826823

Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III cannot Be Reliably Reduced for Predicting Time to Initiation of Parkinsonian Medication in Early Parkinson's Disease: An Item-Level Sensitivity Analysis.

Alam MS, Stebbins GT, Mestre TA, Goetz CG, Luo S.

Mov Disord Clin Pract · 2026-10-02

DOI: 10.1002/mdc3.70843PMID: 42827329

Neuroprotective Effects of Celastrus paniculatus Seed Oil in Rotenoneinduced Parkinson's Disease in Wistar Rats.

Rao BV, Sushma R, Ramya V, Santhosh G.

Curr Aging Sci · 2026-10-02

DOI: 10.2174/0118746098520196260928174332PMID: 42861809

Oscillopathic features and neuromodulation with tACS in people with Parkinson's disease: A semi-systematic review.

Opie GM.

Neurosci Biobehav Rev · 2026-10-02

DOI: 10.1016/j.neubiorev.2026.107006PMID: 42822133

NADPH Oxidase-Related Oxidative Stress in Parkinson’s Disease-Associated Cognitive Impairment: An Evidence-Focused Review

Choi D, Choi I.

Antioxidants (Basel, Switzerland) · 2026-10-01

Lipid Dysregulation and Impaired Resolution of Inflammation in Genetic Forms of Parkinson’s Disease: Potential Links and Knowledge Gaps

Gerasimova T, Novosadova E, Stepanenko E, Eremeev A, Nenasheva V.

Biomedicines · 2026-10-01

Neuroimaging Evidence of Acupuncture Effects in Parkinson’s Disease: A Systematic Review of fMRI-Based Clinical Studies

Pereira C, Greten H, Santos R, Reis A, Ramos B, Santos M, Machado J, Pereira F, de Oliveira N, Criado M.

Healthcare (Basel, Switzerland) · 2026-10-01

Integrative Genetic and Transcriptomic Analysis Reveals Candidate Molecular Differences Among Dementia with Lewy Bodies, Alzheimer’s Disease, and Parkinson’s Disease Dementia

Öztan G, İşsever T, İşsever H.

International journal of molecular sciences · 2026-10-01

Macular Retinal Layer Thickness in Mild-to-Moderate Parkinson’s Disease

Zhu M, Patel S, Daniels N, Hsu J, D’Cunha R, Choi A, Haystead A, Chiu S, Scott B, Grewal D, Fekrat S.

Diagnostics (Basel, Switzerland) · 2026-10-01

In Silico Evaluation of Cyanobacteria-Derived Bioactive Compounds as Potential Monoamine Oxidase-B Inhibitors for Parkinson’s Disease: Molecular Docking and Molecular Dynamics Simulation Study

Khalid S, Ahmad S, Kaushik A, Sebaei M, Soliman W, Zaidi N, Tripathi R, Nafees S, Rumman M, Yasin D.

Pharmaceuticals (Basel, Switzerland) · 2026-10-01